489 related articles for article (PubMed ID: 14668111)
21. Urinary arsenic methylation capability and carotid atherosclerosis risk in subjects living in arsenicosis-hyperendemic areas in southwestern Taiwan.
Huang YL; Hsueh YM; Huang YK; Yip PK; Yang MH; Chen CJ
Sci Total Environ; 2009 Apr; 407(8):2608-14. PubMed ID: 19187952
[TBL] [Abstract][Full Text] [Related]
22. Cytotoxicity of combinations of arsenicals on rat urinary bladder urothelial cells in vitro.
Nascimento MG; Suzuki S; Wei M; Tiwari A; Arnold LL; Lu X; Le XC; Cohen SM
Toxicology; 2008 Jul; 249(1):69-74. PubMed ID: 18502017
[TBL] [Abstract][Full Text] [Related]
23. Serum beta-carotene level, arsenic methylation capability, and incidence of skin cancer.
Hsueh YM; Chiou HY; Huang YL; Wu WL; Huang CC; Yang MH; Lue LC; Chen GS; Chen CJ
Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):589-96. PubMed ID: 9264271
[TBL] [Abstract][Full Text] [Related]
24. A biokinetic model to describe the distribution and excretion of arsenic by man following acute and chronic intakes of arsenite/arsenate compounds by ingestion.
Adeyemi A; Garelick H; Priest ND
Hum Exp Toxicol; 2010 Nov; 29(11):891-902. PubMed ID: 20219843
[TBL] [Abstract][Full Text] [Related]
25. NTP Toxicology and Carcinogenesis Studies of Methyleugenol (CAS NO. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2000 Jul; 491():1-412. PubMed ID: 12563349
[TBL] [Abstract][Full Text] [Related]
26. Understanding arsenic carcinogenicity by the use of animal models.
Wanibuchi H; Salim EI; Kinoshita A; Shen J; Wei M; Morimura K; Yoshida K; Kuroda K; Endo G; Fukushima S
Toxicol Appl Pharmacol; 2004 Aug; 198(3):366-76. PubMed ID: 15276416
[TBL] [Abstract][Full Text] [Related]
27. Effects of inorganic arsenic on the rat and mouse urinary bladder.
Suzuki S; Arnold LL; Ohnishi T; Cohen SM
Toxicol Sci; 2008 Dec; 106(2):350-63. PubMed ID: 18728046
[TBL] [Abstract][Full Text] [Related]
28. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms underlying arsenic carcinogenesis: hypersensitivity of mice exposed to inorganic arsenic during gestation.
Waalkes MP; Liu J; Ward JM; Diwan BA
Toxicology; 2004 May; 198(1-3):31-8. PubMed ID: 15138027
[TBL] [Abstract][Full Text] [Related]
30. Determination of arsenicals in mouse tissues after simulated exposure to arsenic from rice for sixteen weeks and the effects on histopathological features.
Wang J; Zhang G; Lin Z; Luo Y; Fang H; Yang L; Xie J; Guo L
Ecotoxicol Environ Saf; 2020 Sep; 200():110742. PubMed ID: 32470681
[TBL] [Abstract][Full Text] [Related]
31. Arsenic species that cause release of iron from ferritin and generation of activated oxygen.
Ahmad S; Kitchin KT; Cullen WR
Arch Biochem Biophys; 2000 Oct; 382(2):195-202. PubMed ID: 11068869
[TBL] [Abstract][Full Text] [Related]
32. Forced uptake of trivalent and pentavalent methylated and inorganic arsenic and its cyto-/genotoxicity in fibroblasts and hepatoma cells.
Dopp E; Hartmann LM; von Recklinghausen U; Florea AM; Rabieh S; Zimmermann U; Shokouhi B; Yadav S; Hirner AV; Rettenmeier AW
Toxicol Sci; 2005 Sep; 87(1):46-56. PubMed ID: 15947026
[TBL] [Abstract][Full Text] [Related]
33. Inorganic arsenic-induced intramitochondrial granules in mouse urothelium.
Suzuki S; Arnold LL; Muirhead D; Lu X; Le XC; Bjork JA; Wallace KB; Ohnishi T; Kakiuchi-Kiyota S; Pennington KL; Cohen SM
Toxicol Pathol; 2008 Dec; 36(7):999-1005. PubMed ID: 19126794
[TBL] [Abstract][Full Text] [Related]
34. Toxicology and Carcinogenesis Studies of 5,5-Diphenylhydantoin (CAS No. 57-41-0) (Phenytoin) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Nov; 404():1-303. PubMed ID: 12621514
[TBL] [Abstract][Full Text] [Related]
35. Arsenic-induced dyslipidemia in male albino rats: comparison between trivalent and pentavalent inorganic arsenic in drinking water.
Afolabi OK; Wusu AD; Ogunrinola OO; Abam EO; Babayemi DO; Dosumu OA; Onunkwor OB; Balogun EA; Odukoya OO; Ademuyiwa O
BMC Pharmacol Toxicol; 2015 Jun; 16():15. PubMed ID: 26044777
[TBL] [Abstract][Full Text] [Related]
36. Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes.
Petrick JS; Ayala-Fierro F; Cullen WR; Carter DE; Vasken Aposhian H
Toxicol Appl Pharmacol; 2000 Mar; 163(2):203-7. PubMed ID: 10698679
[TBL] [Abstract][Full Text] [Related]
37. Assessing the human health risks from exposure of inorganic arsenic through oyster (Crassostrea gigas) consumption in Taiwan.
Liu CW; Liang CP; Huang FM; Hsueh YM
Sci Total Environ; 2006 May; 361(1-3):57-66. PubMed ID: 16122780
[TBL] [Abstract][Full Text] [Related]
38. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
39. NTP Toxicology and Carcinogenesis Studies of Oxazepam (CAS No. 604-75-1) in Swiss-Webster and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Aug; 443():1-321. PubMed ID: 12595920
[TBL] [Abstract][Full Text] [Related]
40. NTP technical report on toxicity studies of urethane in drinking water and urethane in 5% ethanol administered to F344/N rats and B6C3F1 mice.
Chan PC
Toxic Rep Ser; 1996 Mar; (52):1-91, A1-9, B1-9 passim. PubMed ID: 11803705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
